Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd has informed the BSE that the trading window for dealing in its securities will remain closed from 1st April 2026 until 48 hours after the announcement of its audited financial results for the half year and full year ended 31st March 2026. This closure is in compliance with SEBI's Insider Trading Regulations, 2015, and is a routine step taken before declaring financial results to prevent insider trading. The intimation is signed by Managing Director Siddharth Kanakia. The company is listed under scrip code 540468 on BSE.
This is a routine regulatory compliance filing and does not carry any material impact on shareholders or the stock price. Insiders, including directors and employees, are restricted from trading in the company's shares during this period until results are announced.